Internet Archive Scholar

Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer

Daisy Elliott, Freddie C. Hamdy, Tom A. Leslie, Derek Rosario, Tim Dudderidge, Richard Hindley, Mark Emberton, Simon Brewster, Prasanna Sooriakumaran, James W.F. Catto, Amr Emara, Hashim Ahmed (+3 others)
2018 BJU International  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (209.8 kB)
https://web.archive.org/web/20190501134722/https://research-information.bristol.ac.uk/files/175855953/ablation.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL. The file type is application/pdf.

General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: Objective To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate-risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment. Conclusion Although clinicians find it challenging to recruit
more » ... ents to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients.
doi:10.1111/bju.14432 pmid:29888845 fatcat:433nobyjtnbjnnozfbyizyllcq
Open Access
Citation

Daisy Elliott, Freddie C. Hamdy, Tom A. Leslie, Derek Rosario, Tim Dudderidge, Richard Hindley, Mark Emberton, Simon Brewster, Prasanna Sooriakumaran, James W.F. Catto, Amr Emara, Hashim Ahmed, Paul Whybrow, Steffi le Conte, Jenny L. Donovan. "Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer." BJU International 122.6 (2018)